SynchNeuro
1 known investors
SynchNeuro develops a non-invasive, behind-the-ear wearable sensor that analyzes brain signals (EEG) to continuously monitor glucose levels, sleep quality, and other metabolic metrics. Aimed at individuals managing metabolic health, especially those with prediabetes, it uses machine-learning models as a pain-free alternative to traditional glucose monitoring.
AI & Machine LearningDigital HealthMedical Devices
Founders & leadership
CH
Casey HalpernFounder & Chairman
EM
Emily MirroCo-Founder & President
HL
Heonsoo LeeChief Scientist